Results 191 to 200 of about 1,765 (298)

Multirobot Collaborative Pursuit Target Robot by Improved MADDPG.

open access: yesComput Intell Neurosci, 2022
Zhou X, Zhou S, Mou X, He Y.
europepmc   +1 more source

SOLUTION OF SIMPLE PURSUIT-EVASION PROBLEM WHEN EVADER MOVES ON A GIVEN CURVE

open access: yes
We investigate a simple motion pursuit-evasion differential game of one Pursuer and one Evader. Maximal speeds of the players are equal. The Evader moves along a given curve without self-intersection.
ATAMURAT SH. KUCHKAROV
core  

Targeting the PHB2–ACSL3 Lipid‐Remodeling Axis Overcomes Cisplatin Resistance by Restoring Ferroptosis in Gastric Cancer

open access: yesAdvanced Science, EarlyView.
ABSTRACT Platinum‐based chemotherapy resistance remains a major obstacle in gastric cancer (GC) treatment. Through integrated transcriptomic profiling of cisplatin‐resistant xenografts and pharmacogenomic interrogation of the NCI‐60 dataset, we identified Prohibitin‐2 (PHB2) as a previously unrecognized determinant of chemoresistance.
Liang Xu   +10 more
wiley   +1 more source

Tissue‐Agnostic Cellular Morphometric Biomarkers for Risk‐Adapted Management Across Gastrointestinal Precancerous Lesions and Cancers

open access: yesAdvanced Science, EarlyView.
An interpretable, unsupervised artificial intelligence framework identifies a 13‐cellular morphometric biomarker (CMB) signature from routine H&E whole‐slide images. Validated across 2,602 patients, the fixed signature generalizes across colorectal, gastric, and esophageal tissues without retraining, stratifies prognosis and precancerous lesion risk ...
Pin Wang   +14 more
wiley   +1 more source

Andes virus from the 2026 <i>MV Hondius</i> outbreak does not show enhanced entry into human cells. [PDF]

open access: yesEmerg Microbes Infect
Carrascosa-Sàez M   +3 more
europepmc   +1 more source

Repurposing FDA‐Approved Drugs to Inhibit Fungal PPTases for Broad‐Spectrum Synergy

open access: yesAdvanced Science, EarlyView.
Fungal secondary metabolites serve as crucial virulence effectors; however, the potential of their biosynthetic pathways as antifungal targets remains inadequately comprehended. Repurposed FDA‐approved drugs inhibit fungal PPTase (essential for secondary metabolism) in vivo.
Zili Song   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy